RNS Number:8298X
Sagentia Group AG
06 June 2007



                               SAGENTIA GROUP AG

                                ('The Company')


On the 5th June, 2007 Christopher Masters, a non executive director and Chairman
of the Board of Directors of Sagentia Group AG, informed the Company that
earlier that day he purchased an additional 150,000 shares of CHF 0.10 each
in Sagentia Group AG at 5.25 pence per share. His total holding of CHF 0.10
shares now stands at 250,000 shares.


In addition on the 5th June 2007 Johan Bjorklund, a non executive director of
Sagentia Group AG and Chief Executive Officer of the Company's largest
shareholder, Catella Switzerland AG (48.8%) and former chairman of the Company,
informed the Company that earlier that day he purchased an additional 150,000
shares of CHF 0.10 each in Sagentia Group AG at 5.25 pence per share. His total
holding of CHF 0.10 shares now stands at 1,270,510 shares.



Enquiries:


Sagentia Group AG
Martin Frost                  (44) 1223 875200


www.sagentiagroup.com


Hansard Group
Andrew Tan                    (44) 207 2451100


www.hansardgroup.co.uk


Notes to editors:



Sagentia Group AG


Sagentia Group is a leading international technology consulting and venturing
organisation, with a reputation for successfully commercialising emerging
science and technology. The Group comprises two principal operating companies,
Sagentia and Chord Capital.


Sagentia is one of the world's pre-eminent technology management and product
development companies. For 20 years the business has shown an unwavering
commitment to innovation that has led to the launch of breakthrough products.


Sagentia's facilities include state-of-the-art laboratories and are located in
Europe in Cambridge, Frankfurt, and Stockholm; in Boston and Baltimore in the
USA and in Hong Kong.


The Group's venture management activities are managed through its FSA-regulated
fund manager Chord Capital Limited. Through Chord Capital, venture and investee
companies gain access to business building and corporate finance skills. Recent
ventures and investments include CMR Fuel Cells plc and Nanoscience plc, listed
on AIM, Sphere Medical Ltd and Atraverda Ltd.


Sagentia Group is quoted on the LSE (SGA.L)



                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
RDSSSAFMISWSELM
Sagentia Grp (LSE:SGA)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Sagentia Grp Charts.
Sagentia Grp (LSE:SGA)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Sagentia Grp Charts.